Abstract
First-Line Treatment with R-CHOP Vs Dose-Adjusted R-EPOCH for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have